Friday's top analyst upgrades and downgrades included Agilent Technologies, Aurora Cannabis, Best Buy, Box, Marvell Technology, Nvidia, Palo Alto Networks, Roku, Splunk and TJX Companies.
Protagonist Therapeutics shares jumped on Wednesday after the company announced preliminary results from its midstage study for patients with transfusion-dependent beta-thalassemia.
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Atlassian, Match, NextEra Energy, Nordstom, Office Depot, Roku, Stamps.com and Tanger Factory...
Protagonist Therapeutics shares made a solid gain on Thursday after the company announced a key update from the FDA.
Protagonist Therapeutics shares saw a solid gain on Monday after the firm announced positive results from its midstage trial in patients with ulcerative colitis. This comes after some controversy...
When companies see their shares rise almost 50%, investors probably just assume the news is from a buyout or a merger. In Tuesday's massive gain in shares of Protagonist Therapeutics, it was that the...
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just assumed this was a takeover or that the company had major news shaking the...
Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Biogen, Broadcom, Devon Energy, Gilead Sciences, Mondelez and Urban Outfitters.
Four companies successfully launched initial public offerings (IPOs) last week and reaped a total of $650 million in new capital. Only two got modest first-day pops however. There are four more IPOs...
Protagonist Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Source: White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett released the conglomerate’s stock holdings as of March 31, 2013. This 13F filing with the SEC shows...
Source: White House Photo by Pete SouzaBerkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett may have surprised the markets with the $28 billion purchase of H.J. Heinz Company (NYSE: HNZ),...
Source: Mark Hirschey / Wikimedia CommonsBerkshire Hathaway Inc. (NYSE: BRK-B) (NYSE: BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings. Many changes had been...